MetLife said net income available to common shareholders for the 3 months ended June 30, 2025 was $698 million and for the 6 months was $1.6 billion, compared to $912 million and $1.7 billion for the same periods in the prior year. The company said adjusted earnings available to common shareholders for the 3 months was $1.4 billion and for the 6 months was $2.7 billion, compared to $1.6 billion and $3.0 billion in the prior year.

1. 01

   MetLife said net income available to common shareholders for the 3 months ended June 30, 2025 was $698 million and for the 6 months was $1.6 billion, compared to $912 million and $1.7 billion for the same periods in the prior year. The company said adjusted earnings available to common shareholders for the 3 months was $1.4 billion and for the 6 months was $2.7 billion, compared to $1.6 billion and $3.0 billion in the prior year.

2. 02

   MetLife said adjusted earnings for the 3 months ended June 30, 2025 decreased $266 million compared to the prior year. The company cited market factors decreasing earnings by $126 million, underwriting and other insurance adjustments decreasing earnings by $201 million, and foreign currency decreasing earnings by $23 million as factors.

3. 03

   MetLife said net derivative gains (losses) changed unfavorably by $288 million for the 3 months and favorably by $1.1 billion for the 6 months. The effective tax rate was 25% for the 3 months (compared to 21% in the prior year) and 28% for the 6 months (compared to 19% in the prior year).

4. 04

   On April 30, 2025, MetLife entered into a definitive agreement with Talcott Resolution Life Insurance Company to reinsure approximately $10.0 billion of variable annuity and rider reserves, with the transaction expected to close in the second half of 2025. As of June 30, 2025, short-term liquidity was $21.5 billion and liquid assets were $183.3 billion.

Key figures

Quarter ended June 30, 2025

Revenue

$17.3B

Operating income

$1.4B

Net income

$729M

EPS

$1.03

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.